Vitamin C versus placebo in prevention of preeclampsia in high risk patients: a randomized controlled trial

Vitamin C versus placebo in prevention of preeclampsia in high risk patients: a randomized controlled tria

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201802002759357

Enrollment

940

Registered

2017-11-13

Start date

2017-11-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth preeclampsia

Interventions

vitamin C group

placebo group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: pregnant patients with: Essential hypertension Renal disease past or family history of preeclampsia Any other risk factors for preeclampsia except diabetes mellitus

Exclusion criteria

Exclusion criteria: Hypersensitvity to treatment Diabetes mellitus

Design outcomes

Primary

Measure	Time frame
development of preeclampsia	—

Secondary

Measure	Time frame
Fetal outcome	—

Countries

Egypt

Contacts

Public ContactHaitham Torky

October 6th University

Haithamtorky@yahoo.com+201001230161

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026